Ganoderma lucidum (Reishi mushroom) for cancer treatment.
- 2016-04-05
- Meta-Analysis
- The Cochrane database of systematic reviews 2019(1)
- Xingzhong Jin
- Julieta Ruiz Beguerie
- Daniel Man-Yeun Sze
- Godfrey C F Chan
- PubMed: 27045603
- DOI: 10.1002/14651858.cd007731.pub3
- High evidence
- Clinical
patients who had been given G. lucidum alongside with chemo/radiotherapy were more likely to respond positively compared to chemo/radiotherapy alone (RR 1.50; 95% CI 0.90 to 2.51, P = 0.02)
- Effect
- Beneficial
- Effect size
- Moderate
- Significant
- No